Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) & Region - Global Forecast to

Leukapheresis Market by Product (Devices, Filters, Membrane Separators), Leukopak (Mobilized, Non-Mobilized), Indication (ALL, NHL, Multiple Myeloma), Application (Research, Therapeutic), End User (Hospitals, Pharma, Biotech) & Region - Global Forecast to 2028



The global leukapheresis products market is predicted to reach USD 100 million by 2028 from USD 70 million in 2023, at a CAGR of 8.3%. The global leukopaks market is predicted to reach USD 1020 million by 2028 from USD 200 million in 2023, at a CAGR of 38.1%. Due to the cases of leukemia rising globally, and rising need for leukopaks in clinical trials and other research applications, the leukapheresis market is expected to grow in the forecast period.

“The research applications accounted for a larger share of the leukapheresis products market.”

By, application, the leukpaheresis products market is segmented into research applications and therapeutic applications. The research applications segment accounted for the larger share of the leukapheresis products market in 2022. The growing development of cell-based immunotherapies and rising demand for leukapheresis-derived primary cells in drug development are some of the major factors driving the growth of the leukapheresis products market during the forecast period.

“The academic & research institutes segment accounted for the largest share of the leukopaks market.”

By end user, the leukopaks market is segmented into academic & research institutes, pharmaceutical & biotechnology companies, and contract research organizations. In 2022, the academic & research institutes segment accounted for the largest share of the leukapheresis products market. The increasing number of industry-academic partnerships for conducting research on cell-based cancer therapies is driving the growth of this end-user segment.

“Asia Pacific will grow at highest CAGR during the forecast period.“

In 2022, Asia Pacific will grow at highest CAGR during the forecast period. The Asia Pacific region is expected to be the fastest growing region in the forecast period. The increasing CAR-T cell therapy research and rising number of pharma & biotech companies and research institutes in China are some of the factors driving market growth. In 2022, China accounted for the largest share of the Asia Pacific leukopaks market. The large share of China can be attributed mainly to the presence of a number of cellular immunotherapy companies in the country.

The break-up of the profile of primary participants in the leukapheresis products market: Supply-side

By Company Type (Supply-side): Tier 1: 35%, Tier 2: 30%, and Tier 3: 35%

By Designation: C-level: 30%, Director-level: 30%, and Others: 40%

By Region: North America: 45%, Europe: 25%, Asia-Pacific: 20%, and Rest of the World: 10%

The break-up of the profile of primary participants in the leukopaks market: Supply-side

By Company Type (Supply-side): Tier 1: 44%, Tier 2: 36%, and Tier 3: 20%

By Designation: C-level: 44%, Director-level: 33%, and Others: 23%

By Region: North America: 40%, Europe: 25%, Asia-Pacific: 20%, and Rest of the World: 15%

Prominent players in the leukapheresis products market include Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany).

Some prominent players in the leukopaks market are Discovery Life Sciences (US), StemExpress, LLC (US), Charles River Laboratories International, Inc. (US), Caltag Medsystems Limited (UK), Lonza Group AG (Switzerland), and ZenBio (US).

Research Coverage:

The report analyzes the leukapheresis market and aims at estimating the market size and future growth potential of this market based on various segments such as product, and region. The report also includes competitive analysis of the key players in this market along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall leukapheresis market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

Analysis of key drivers (rising incidence and prevalence of leukemia, increasing number of blood donations, increased demand for leukopaks in clinical research), restraints (high cost of therapeutic leukapheresis and leukopaks, stringent donor recruitment criteria, complications associated with therapeutic leukapheresis), opportunities (leukapheresis for pediatric patients, emerging economies with investments from academic institutes, pharma-biotech companies, and leading players), and challenges (blood transfusion safety in emerging countries) influencing the growth of the leukapheresis market

Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the leukapheresis market

Market Development: Comprehensive information on the lucrative emerging markets by type, usage, end user and region.

Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global leukapheresis market.

Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Asahi Kasei Corporation (Japan), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Terumo BCT, Inc. (US), Macopharma SA (France), and Miltenyi Biotec (Germany) in the global leukapheresis market.


  • INTRODUCTION
    • STUDY OBJECTIVES
    • MARKET DEFINITION
      • TYPE
      • APPLICATION
      • END USER
      • INCLUSIONS AND EXCLUSIONS
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED
    • CURRENCY CONSIDERED
      • Table STANDARD CURRENCY CONVERSION RATES
    • STAKEHOLDERS
    • SUMMARY OF CHANGES
    • RECESSION IMPACT
  • RESEARCH METHODOLOGY
    • RESEARCH DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • MARKET SIZE ESTIMATION: LEUKAPHERESIS PRODUCTS MARKET
    • MARKET SIZE ESTIMATION: LEUKOPAKS MARKET
    • MARKET BREAKDOWN AND DATA TRIANGULATION
    • MARKET SHARE ANALYSIS
    • RESEARCH ASSUMPTIONS
    • RISK ASSESSMENT
      • Table RISK ASSESSMENT: LEUKAPHERESIS PRODUCTS AND LEUKOPAKS MARKETS
    • METHODOLOGY-RELATED LIMITATIONS
    • RECESSION IMPACT ANALYSIS
  • EXECUTIVE SUMMARY
  • PREMIUM INSIGHTS
    • LEUKAPHERESIS PRODUCTS MARKET: OVERVIEW
    • NORTH AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE AND COUNTRY
    • LEUKAPHERESIS PRODUCTS MARKET: GEOGRAPHIC MIX
    • LEUKAPHERESIS PRODUCTS MARKET: REGIONAL MIX
    • LEUKOPAKS MARKET: OVERVIEW
    • NORTH AMERICA: LEUKOPAKS MARKET, BY PRODUCT AND COUNTRY
    • LEUKOPAKS MARKET: GEOGRAPHIC MIX
    • LEUKOPAKS MARKET: REGIONAL MIX
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
      • RESTRAINTS
        • Table COST OF LEUKOPAKS, BY TYPE
        • Table DONOR SELECTION CRITERIA
        • Table FREQUENCY OF BLOOD DONATION FROM HEALTHY DONORS
      • OPPORTUNITIES
      • CHALLENGES
    • PORTER’S FIVE FORCES ANALYSIS
      • Table LEUKAPHERESIS MARKET: PORTER’S FIVE FORCES ANALYSIS
      • THREAT FROM NEW ENTRANTS
      • THREAT FROM SUBSTITUTES
      • BARGAINING POWER OF SUPPLIERS
      • BARGAINING POWER OF BUYERS
      • INTENSITY OF COMPETITIVE RIVALRY
    • INDUSTRY TRENDS
      • INCREASING COLLABORATIONS BETWEEN PHARMA AND BIOTECH COMPANIES
        • Table RECENT DEVELOPMENTS RELATED TO CAR-T THERAPY
      • INTRODUCTION OF CUSTOMIZABLE CRYOPRESERVED LEUKOPAKS
    • TECHNOLOGY ANALYSIS
      • KEY TECHNOLOGIES
        • Table MATERIALS USED FOR LEUKOCYTE FILTRATION AND SURFACE MODIFICATION TECHNIQUES APPLIED FOR ENHANCED SEPARATION
      • EMERGING TECHNOLOGIES
    • PRICING ANALYSIS (LEUKOPAKS MARKET)
      • Table ASP OF NON-MOBILIZED LEUKOPAKS
      • Table ASP OF MOBILIZED LEUKOPAKS
      • Table ASP OF MOBILIZED ISOLATED CELLS
    • KEY CONFERENCES AND EVENTS, 2023-2024
      • Table LEUKAPHERESIS MARKET: CONFERENCES AND EVENTS
    • REGULATORY ANALYSIS (LEUKAPHERESIS PRODUCTS MARKET)
      • NORTH AMERICA
      • EUROPE
      • ASIA PACIFIC
    • REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
      • Table MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • REGULATORY ANALYSIS (LEUKOPAKS MARKET)
      • US
        • Table LIST OF FDA-APPROVED CAR-T THERAPEUTICS
      • EUROPE
      • JAPAN
      • INDIA
    • VALUE CHAIN ANALYSIS
    • SUPPLY CHAIN ANALYSIS
    • ECOSYSTEM ANALYSIS
      • Table LEUKAPHERESIS MARKET: ECOSYSTEM
    • HS CODES: CENTRIFUGAL DEVICES AND MEMBRANE SEPARATORS
    • PATENT ANALYSIS
      • PATENT PUBLICATION TRENDS IN LEUKAPHERESIS PRODUCTS MARKET
      • PATENT PUBLICATION TRENDS IN LEUKOPAKS MARKET
      • TOP APPLICANTS FOR LEUKAPHERESIS PRODUCT PATENTS
      • TOP APPLICANTS FOR LEUKOPAK PATENTS
      • JURISDICTION ANALYSIS: TOP COUNTRIES FOR LEUKAPHERESIS MARKET PATENTS
      • TOP PATENT APPLICANTS/OWNERS
        • Table LEUKAPHERESIS PRODUCTS MARKET: MAJOR PATENTS (2020-2022)
        • Table LEUKOPAKS MARKET: MAJOR PATENTS (2019-2022)
    • KEY STAKEHOLDERS AND BUYING CRITERIA
      • KEY STAKEHOLDERS IN BUYING PROCESS
        • Table INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR LEUKAPHERESIS PRODUCTS AND LEUKOPAKS
      • BUYING CRITERIA
        • Table KEY BUYING CRITERIA FOR LEUKAPHERESIS PRODUCTS AND LEUKOPAKS
    • CASE STUDIES
      • Table CASE STUDY 1: ESTIMATING MARKET SIZE OF LEUKAPHERESIS PRODUCTS AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL
      • Table CASE STUDY 2: ESTIMATING MARKET SIZE OF LEUKOPAKS AND MARKET SHARE ANALYSIS FOR KEY PRODUCTS AT COUNTRY LEVEL
    • ADJACENT MARKET ANALYSIS
      • PLASMA FRACTIONATION MARKET
      • APHERESIS MARKET
  • LEUKAPHERESIS PRODUCTS MARKET, BY TYPE
    • INTRODUCTION
      • Table LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • DISPOSABLES
      • RECURRENT DEMAND TO BOOST SEGMENT
        • Table LEUKOREDUCTION FILTER MANUFACTURERS
        • Table LEUKAPHERESIS COLUMN AND CELL SEPARATOR MANUFACTURERS
        • Table DISPOSABLES: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • DEVICES
      • Table DEVICES: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table DEVICES: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • CENTRIFUGAL DEVICES
        • Table CENTRIFUGAL DEVICES AVAILABLE
        • Table CENTRIFUGAL DEVICES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
      • MEMBRANE SEPARATORS
        • Table MEMBRANE SEPARATORS AVAILABLE
        • Table MEMBRANE SEPARATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION
    • INTRODUCTION
      • Table LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • RESEARCH APPLICATIONS
      • GROWING NUMBER OF CLINICAL TRIALS TO DRIVE SEGMENT
        • Table COMPANIES DEVELOPING FDA-APPROVED CAR-T CELL THERAPIES
        • Table RESEARCH APPLICATIONS: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • THERAPEUTIC APPLICATIONS
      • RISING ADOPTION OF LEUKAPHERESIS FOR LEUKEMIA TREATMENT TO FUEL MARKET
        • Table THERAPEUTIC APPLICATIONS: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • LEUKAPHERESIS PRODUCTS MARKET, BY END USER
    • INTRODUCTION
      • Table LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • BLOOD COMPONENT PROVIDERS & BLOOD CENTERS
      • INCREASING BLOOD DONATION TO DRIVE MARKET
        • Table BLOOD COMPONENT PROVIDERS & BLOOD CENTERS: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • COLLABORATIONS WITH PHARMACEUTICAL COMPANIES TO BOOST MARKET
        • Table ACADEMIC & RESEARCH INSTITUTES: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • INCREASING NUMBER OF CLINICAL TRIALS TO DRIVE SEGMENT
        • Table PHARMA-BIOTECH COMPANIES DEVELOPING CAR-T CELL TECHNOLOGIES
        • Table PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • HOSPITALS & TRANSFUSION CENTERS
      • GROWING NEED FOR TRANSFUSIONS TO PROPEL MARKET
        • Table HOSPITALS & TRANSFUSION CENTERS: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • LEUKOPAKS MARKET, BY TYPE
    • INTRODUCTION
      • Table LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
      • Table LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • MOBILIZED LEUKOPAKS
      • INCREASING USE IN CLINICAL RESEARCH TO DRIVE MARKET
        • Table TREATMENT REGIMENS FOR DEVELOPMENT OF MOBILIZED LEUKOPAKS
        • Table MOBILIZED LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table MOBILIZED LEUKOPAKS MARKET, BY REGION, 2021-2028 (UNITS)
    • NON-MOBILIZED LEUKOPAKS
      • LOW COST TO PROPEL MARKET
        • Table NUMBER OF CELLS IN NON-MOBILIZED LEUKOPAKS
        • Table COMPARATIVE ANALYSIS OF MOBILIZED AND NON-MOBILIZED LEUKOPAKS
        • Table COMPOSITION OF MOBILIZED AND NON-MOBILIZED LEUKOPAKS
        • Table NON-MOBILIZED LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NON-MOBILIZED LEUKOPAKS MARKET, BY REGION, 2021-2028 (UNITS)
    • DISEASED LEUKOPAKS
      • RISING USE FOR CELL INTERACTION AND DRUG TOXICITY STUDIES TO BOOST MARKET
        • Table DISEASED LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table DISEASED LEUKOPAKS MARKET, BY REGION, 2021-2028 (UNITS)
    • ISOLATED PBMCS
      • INCREASING RESEARCH FOCUS ON CELL-BASED THERAPIES TO FUEL MARKET
        • Table IMMUNE CELL TYPES AND TARGETED DISEASES
        • Table ISOLATED PBMCS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ISOLATED PBMCS MARKET, BY REGION, 2021-2028 (UNITS)
  • LEUKOPAKS MARKET, BY INDICATION
    • INTRODUCTION
      • Table LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
    • ACUTE LYMPHOCYTIC LEUKEMIA
      • RISING INCIDENCE OF DISEASE TO DRIVE MARKET
        • Table ACUTE LYMPHOCYTIC LEUKEMIA: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • MULTIPLE MYELOMA
      • RISING DIAGNOSIS RATE TO FUEL SEGMENT
        • Table MULTIPLE MYELOMA: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • NON-HODGKIN’S LYMPHOMA
      • DEVELOPMENT OF NOVEL THERAPIES TO BOOST MARKET
        • Table NON-HODGKIN’S LYMPHOMA: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • CHRONIC LYMPHOCYTIC LEUKEMIA
      • RISING NUMBER OF CASES TO PROPEL MARKET
        • Table CHRONIC LYMPHOCYTIC LEUKEMIA: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PANCREATIC CANCER
      • DEVELOPMENT OF NEW DIAGNOSTIC TECHNIQUES TO DRIVE SEGMENT
        • Table PANCREATIC CANCER: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • HEPATOCELLULAR CARCINOMA
      • INCREASING INCIDENCE OF VIRAL HEPATITIS TO FUEL SEGMENT
        • Table HEPATOCELLULAR CARCINOMA: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • OTHER INDICATIONS
      • Table OTHER INDICATIONS: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • LEUKOPAKS MARKET, BY END USER
    • INTRODUCTION
      • Table LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • ACADEMIC & RESEARCH INSTITUTES
      • INCREASING INDUSTRY-ACADEMIC RESEARCH PARTNERSHIPS TO DRIVE MARKET
        • Table ACADEMIC & RESEARCH INSTITUTES: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
      • RISING DEMAND FOR TARGET DRUG DEVELOPMENT TO PROPEL MARKET
        • Table PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • CONTRACT RESEARCH ORGANIZATIONS
      • INCREASING CLINICAL TRIAL SPONSORSHIP TO DRIVE MARKET
        • Table CONTRACT RESEARCH ORGANIZATIONS: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
  • LEUKAPHERESIS MARKET, BY REGION
    • INTRODUCTION
      • Table LEUKAPHERESIS PRODUCTS MARKET, BY REGION, 2021-2028 (USD MILLION)
      • Table LEUKOPAKS MARKET, BY REGION, 2021-2028 (USD MILLION)
    • NORTH AMERICA
      • RECESSION IMPACT: NORTH AMERICA
        • Table NORTH AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table NORTH AMERICA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • US
        • Table DIAGNOSIS-RELATED GROUP REIMBURSEMENT (DRG)
        • Table US: KEY MACROINDICATORS
        • Table US: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table US: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table US: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table US: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table US: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CANADA
        • Table CANADA: KEY MACROINDICATORS
        • Table CANADA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CANADA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table CANADA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CANADA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table CANADA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • EUROPE
      • RECESSION IMPACT: EUROPE
        • Table EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table EUROPE: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • UK
        • Table UK: KEY MACROINDICATORS
        • Table UK: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table UK: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table UK: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table UK: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table UK: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • GERMANY
        • Table GERMANY: KEY MACROINDICATORS
        • Table GERMANY: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table GERMANY: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table GERMANY: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table GERMANY: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table GERMANY: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SPAIN
        • Table SPAIN: KEY MACROINDICATORS
        • Table SPAIN: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SPAIN: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table SPAIN: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SPAIN: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table SPAIN: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • FRANCE
        • Table FRANCE: KEY MACROINDICATORS
        • Table FRANCE: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table FRANCE: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table FRANCE: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table FRANCE: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table FRANCE: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • ITALY
        • Table ITALY: COMMERCIAL CAR-T CELL THERAPIES APPROVED BY EMA (2022)
        • Table ITALY: KEY MACROINDICATORS
        • Table ITALY: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ITALY: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table ITALY: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ITALY: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table ITALY: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF EUROPE
        • Table REST OF EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table REST OF EUROPE: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • ASIA PACIFIC
      • RECESSION IMPACT: ASIA PACIFIC
        • Table ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKOPAKS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table ASIA PACIFIC: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • CHINA
        • Table CHINA: KEY MACROINDICATORS
        • Table CHINA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table CHINA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table CHINA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table CHINA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table CHINA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • JAPAN
        • Table JAPAN: KEY MACROINDICATORS
        • Table JAPAN: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table JAPAN: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table JAPAN: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table JAPAN: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table JAPAN: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • INDIA
        • Table INDIA: KEY MACROINDICATORS
        • Table INDIA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table INDIA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table INDIA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table INDIA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table INDIA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • AUSTRALIA
        • Table AUSTRALIA: KEY MACROINDICATORS
        • Table AUSTRALIA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table AUSTRALIA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • SOUTH KOREA
        • Table SOUTH KOREA: KEY MACROINDICATORS
        • Table SOUTH KOREA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table SOUTH KOREA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
      • REST OF ASIA PACIFIC
        • Table REST OF ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table REST OF ASIA PACIFIC: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • LATIN AMERICA
      • RECESSION IMPACT: LATIN AMERICA
        • Table LATIN AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table LATIN AMERICA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
    • MIDDLE EAST & AFRICA
      • RECESSION IMPACT: MIDDLE EAST & AFRICA
        • Table MIDDLE EAST & AFRICA: LEUKAPHERESIS PRODUCTS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: LEUKAPHERESIS DEVICES MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: LEUKAPHERESIS PRODUCTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: LEUKAPHERESIS PRODUCTS MARKET, BY END USER, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: LEUKOPAKS MARKET, BY TYPE, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: LEUKOPAKS MARKET, BY INDICATION, 2021-2028 (USD MILLION)
        • Table MIDDLE EAST & AFRICA: LEUKOPAKS MARKET, BY END USER, 2021-2028 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • INTRODUCTION
    • KEY PLAYER STRATEGIES/RIGHT TO WIN
      • OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LEUKAPHERESIS PRODUCTS MARKET
      • OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN LEUKOPAKS MARKET
    • REVENUE SHARE ANALYSIS OF TOP MARKET PLAYERS
    • COMPETITIVE BENCHMARKING (LEUKAPHERESIS PRODUCTS MARKET)
      • Table OVERALL COMPANY FOOTPRINT
      • Table COMPANY END USER FOOTPRINT
      • Table COMPANY APPLICATION FOOTPRINT
      • Table COMPANY REGION FOOTPRINT
    • MARKET SHARE ANALYSIS (LEUKAPHERESIS PRODUCTS, 2022)
      • Table LEUKAPHERESIS PRODUCTS MARKET: DEGREE OF COMPETITION
    • MARKET SHARE ANALYSIS (LEUKOPAKS, 2022)
      • Table LEUKOPAKS MARKET: DEGREE OF COMPETITION
    • COMPANY EVALUATION MATRIX, 2022 (LEUKAPHERESIS PRODUCTS MARKET)
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPETITIVE EVALUATION MATRIX FOR START-UPS/SMES (LEUKAPHERESIS MARKET) (2022)
      • Table LEUKAPHERESIS MARKET: KEY START-UPS/SMES
      • PROGRESSIVE COMPANIES
      • DYNAMIC COMPANIES
      • STARTING BLOCKS
      • RESPONSIVE COMPANIES
    • COMPETITIVE EVALUATION MATRIX, 2022 (LEUKOPAKS MARKET)
      • STARS
      • EMERGING LEADERS
      • PERVASIVE PLAYERS
      • PARTICIPANTS
    • COMPETITIVE SCENARIO AND TRENDS
      • Table PRODUCT LAUNCHES AND APPROVALS (JANUARY 2019-AUGUST 2023)
      • Table DEALS (JANUARY 2019-AUGUST 2023)
      • Table OTHER DEVELOPMENTS (JANUARY 2019-AUGUST 2023)
  • COMPANY PROFILES
    • KEY PLAYERS (LEUKAPHERESIS PRODUCTS MARKET)
      • TERUMO BCT
        • Table TERUMO BCT: COMPANY OVERVIEW
      • FRESENIUS SE & CO. KGAA
        • Table FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW
      • HAEMONETICS CORPORATION
        • Table HAEMONETICS CORPORATION: COMPANY OVERVIEW
      • ASAHI KASEI CORPORATION
        • Table ASAHI KASEI CORPORATION: COMPANY OVERVIEW
      • MACOPHARMA SA
        • Table MACOPHARMA SA: COMPANY OVERVIEW
      • MILTENYI BIOTEC
        • Table MILTENYI BIOTEC: COMPANY OVERVIEW
    • OTHER PLAYERS (LEUKAPHERESIS PRODUCTS MARKET)
      • GUANGZHOU DAJI MEDICAL SCIENCE AND TECHNOLOGY CO. LTD.
        • Table GUANGZHOU DAJI MEDICAL SCIENCE AND TECHNOLOGY CO. LTD.: COMPANY OVERVIEW
      • MEDICA SPA.
        • Table MEDICA SPA: COMPANY OVERVIEW
      • PURIBLOOD MEDICAL CO. LTD.
        • Table PURIBLOOD MEDICAL CO. LTD.: COMPANY OVERVIEW
      • BEIJING ZKSK TECHNOLOGY CO. LTD.
        • Table BEIJING ZKSK TECHNOLOGY CO. LTD.: COMPANY OVERVIEW
      • SB-KAWASUMI LABORATORIES, INC.
        • Table SB-KAWASUMI LABORATORIES, INC.: COMPANY OVERVIEW
      • NIKKISO CO., LTD.
        • Table NIKKISO CO., LTD.: COMPANY OVERVIEW
      • PALL CORPORATION
        • Table PALL CORPORATION: COMPANY OVERVIEW
    • KEY PLAYERS (LEUKOPAKS MARKET)
      • CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
        • Table CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: COMPANY OVERVIEW
      • DISCOVERY LIFE SCIENCES, INC.
        • Table DISCOVERY LIFE SCIENCES, INC.: COMPANY OVERVIEW
      • BIOIVT
        • Table BIOIVT: COMPANY OVERVIEW
      • PRECISION FOR MEDICINE, INC.
        • Table PRECISION FOR MEDICINE, INC.: COMPANY OVERVIEW
      • STEMEXPRESS, LLC
        • Table STEMEXPRESS, LLC: COMPANY OVERVIEW
    • OTHER PLAYERS (LEUKOPAKS MARKET)
      • LONZA GROUP AG
        • Table LONZA GROUP AG: COMPANY OVERVIEW
      • CALTAG MEDSYSTEMS LIMITED
        • Table CALTAG MEDSYSTEMS LIMITED: COMPANY OVERVIEW
      • ZENBIO, INC.
        • Table ZENBIO, INC.: COMPANY OVERVIEW
      • STEMCELL TECHNOLOGIES
      • TRINA BIOREACTIVES AG
      • ACCEGEN
      • FIRST CHOICE BIO LLC
  • APPENDIX
    • DISCUSSION GUIDE
    • KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
    • CUSTOMIZATION OPTIONS
    • RELATED REPORTS
    • AUTHOR DETAILS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings